Cargando…
Control of type 2 diabetes mellitus during the COVID-19 pandemic
AIMS: Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic condition that can lead to significant complications if not well controlled. The COVID-19 pandemic created disruptions in daily life; however, it is unknown whether the pandemic’s disruptions affected the ability for adults with T2DM to co...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Primary Care Diabetes Europe. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449252/ https://www.ncbi.nlm.nih.gov/pubmed/34246614 http://dx.doi.org/10.1016/j.pcd.2021.06.012 |
_version_ | 1784569392536748032 |
---|---|
author | Felix, Holly C. Andersen, Jennifer A. Willis, Don E. Malhis, Joseph R. Selig, James P. McElfish, Pearl A. |
author_facet | Felix, Holly C. Andersen, Jennifer A. Willis, Don E. Malhis, Joseph R. Selig, James P. McElfish, Pearl A. |
author_sort | Felix, Holly C. |
collection | PubMed |
description | AIMS: Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic condition that can lead to significant complications if not well controlled. The COVID-19 pandemic created disruptions in daily life; however, it is unknown whether the pandemic’s disruptions affected the ability for adults with T2DM to control their condition. This study aims to fill the knowledge gap with the experiences of adults with T2DM in Arkansas, U.S. during the COVID-19 pandemic. METHODS: This study analyzed cross-sectional, observational survey data collected from adults (≥18 years) who live, work, or receive healthcare in Arkansas; self-reported a diagnosis of T2DM; and completed the diabetes module of the Impact of COVID-19 online survey (n = 131) fielded in July–August 2020. Descriptive statistics were used to characterize the sample and survey responses, and multivariate regression was used to identify demographics, self-care behaviors, and access issues associated with uncontrolled T2DM (HbA1c ≥ 9% or 74.9 mmol/mol) or with an increase in HbA1c. RESULTS: 28.2% reported an increase in their HbA1c since the pandemic began, and 18.2% had uncontrolled T2DM. Educational level, eating healthily, and weight gain were negatively associated with uncontrolled T2DM. Eating less healthily and having difficulty accessing diabetes related medication were positively associated with an increase in HbA1c. CONCLUSIONS: Adults with T2DM in Arkansas were reasonably able to maintain control of their T2DM during the five months post the first case of COVD-19 diagnosed in the state. However, T2DM self-management interventions targeting those with lower educational levels that are focused on eating habits and/or that improve access to diabetes medication should be considered for future public health emergencies. |
format | Online Article Text |
id | pubmed-8449252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Primary Care Diabetes Europe. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84492522021-09-20 Control of type 2 diabetes mellitus during the COVID-19 pandemic Felix, Holly C. Andersen, Jennifer A. Willis, Don E. Malhis, Joseph R. Selig, James P. McElfish, Pearl A. Prim Care Diabetes Original Research AIMS: Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic condition that can lead to significant complications if not well controlled. The COVID-19 pandemic created disruptions in daily life; however, it is unknown whether the pandemic’s disruptions affected the ability for adults with T2DM to control their condition. This study aims to fill the knowledge gap with the experiences of adults with T2DM in Arkansas, U.S. during the COVID-19 pandemic. METHODS: This study analyzed cross-sectional, observational survey data collected from adults (≥18 years) who live, work, or receive healthcare in Arkansas; self-reported a diagnosis of T2DM; and completed the diabetes module of the Impact of COVID-19 online survey (n = 131) fielded in July–August 2020. Descriptive statistics were used to characterize the sample and survey responses, and multivariate regression was used to identify demographics, self-care behaviors, and access issues associated with uncontrolled T2DM (HbA1c ≥ 9% or 74.9 mmol/mol) or with an increase in HbA1c. RESULTS: 28.2% reported an increase in their HbA1c since the pandemic began, and 18.2% had uncontrolled T2DM. Educational level, eating healthily, and weight gain were negatively associated with uncontrolled T2DM. Eating less healthily and having difficulty accessing diabetes related medication were positively associated with an increase in HbA1c. CONCLUSIONS: Adults with T2DM in Arkansas were reasonably able to maintain control of their T2DM during the five months post the first case of COVD-19 diagnosed in the state. However, T2DM self-management interventions targeting those with lower educational levels that are focused on eating habits and/or that improve access to diabetes medication should be considered for future public health emergencies. Primary Care Diabetes Europe. Published by Elsevier Ltd. 2021-10 2021-06-26 /pmc/articles/PMC8449252/ /pubmed/34246614 http://dx.doi.org/10.1016/j.pcd.2021.06.012 Text en © 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Research Felix, Holly C. Andersen, Jennifer A. Willis, Don E. Malhis, Joseph R. Selig, James P. McElfish, Pearl A. Control of type 2 diabetes mellitus during the COVID-19 pandemic |
title | Control of type 2 diabetes mellitus during the COVID-19 pandemic |
title_full | Control of type 2 diabetes mellitus during the COVID-19 pandemic |
title_fullStr | Control of type 2 diabetes mellitus during the COVID-19 pandemic |
title_full_unstemmed | Control of type 2 diabetes mellitus during the COVID-19 pandemic |
title_short | Control of type 2 diabetes mellitus during the COVID-19 pandemic |
title_sort | control of type 2 diabetes mellitus during the covid-19 pandemic |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449252/ https://www.ncbi.nlm.nih.gov/pubmed/34246614 http://dx.doi.org/10.1016/j.pcd.2021.06.012 |
work_keys_str_mv | AT felixhollyc controloftype2diabetesmellitusduringthecovid19pandemic AT andersenjennifera controloftype2diabetesmellitusduringthecovid19pandemic AT willisdone controloftype2diabetesmellitusduringthecovid19pandemic AT malhisjosephr controloftype2diabetesmellitusduringthecovid19pandemic AT seligjamesp controloftype2diabetesmellitusduringthecovid19pandemic AT mcelfishpearla controloftype2diabetesmellitusduringthecovid19pandemic |